Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal.
02-25-23 Penn Med Campus (Mehak Dhaliwal)
Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal. Mehak Dhaliwal
Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal. Mehak Dhaliwal
The Daily Pennsylvanian is an independent, student-run newspaper. Please consider making a donation to support the coverage that shapes the University. Your generosity ensures a future of strong journalism at Penn.
Donate